These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
460 related articles for article (PubMed ID: 32810384)
1. Individualized prediction of survival benefits from perioperative chemoradiotherapy for patients with resectable gastric cancer. Che K; Liu F; Wu N; Liu Q; Yuan L; Wei J Cancer Med; 2020 Oct; 9(19):7137-7150. PubMed ID: 32810384 [TBL] [Abstract][Full Text] [Related]
2. The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients. Xie J; Pang Y; Li X; Wu X J Cancer Res Clin Oncol; 2021 Aug; 147(8):2259-2269. PubMed ID: 34003367 [TBL] [Abstract][Full Text] [Related]
3. A SEER population analysis of stage IB resected gastric cancer: who can benefit from adjuvant therapy? Wang Y; Guo S; Zhang J; Meng XY; Zheng ZC; Zhao Y Scand J Gastroenterol; 2020 Feb; 55(2):193-201. PubMed ID: 31976783 [No Abstract] [Full Text] [Related]
4. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis. Cheong JH; Yang HK; Kim H; Kim WH; Kim YW; Kook MC; Park YK; Kim HH; Lee HS; Lee KH; Gu MJ; Kim HY; Lee J; Choi SH; Hong S; Kim JW; Choi YY; Hyung WJ; Jang E; Kim H; Huh YM; Noh SH Lancet Oncol; 2018 May; 19(5):629-638. PubMed ID: 29567071 [TBL] [Abstract][Full Text] [Related]
5. A nomogram for prediction of stage III/IV gastric cancer outcome after surgery: A multicenter population-based study. Gao Z; Ni J; Ding H; Yan C; Ren C; Li G; Pan F; Jin G Cancer Med; 2020 Aug; 9(15):5490-5499. PubMed ID: 32543092 [TBL] [Abstract][Full Text] [Related]
6. Nomogram predicting overall survival of rectal squamous cell carcinomas patients based on the SEER database: A population-based STROBE cohort study. Diao JD; Wu CJ; Cui HX; Bu MW; Yue D; Wang X; Liu YL; Yang YJ Medicine (Baltimore); 2019 Nov; 98(46):e17916. PubMed ID: 31725640 [TBL] [Abstract][Full Text] [Related]
7. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer. Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K Front Immunol; 2022; 13():947802. PubMed ID: 36405735 [TBL] [Abstract][Full Text] [Related]
8. Survival benefits of perioperative chemoradiotherapy versus chemotherapy for advanced stage gastric cancer based on directed acyclic graphs. Zheng C; Zhang Y; Cao J; Jing X; Li H PLoS One; 2023; 18(4):e0283854. PubMed ID: 37058499 [TBL] [Abstract][Full Text] [Related]
9. Prediction of all-cause death and specific causes of death in patients with gastric cancer with liver metastasis: a Surveillance, Epidemiology, and End Results-based study. Wu Y; Guo Y; Luo W J Gastrointest Surg; 2024 Jun; 28(6):880-888. PubMed ID: 38616463 [TBL] [Abstract][Full Text] [Related]
10. A nomogram incorporating treatment data for predicting overall survival in gastroenteropancreatic neuroendocrine tumors: a population-based cohort study. Wu Z; Shang G; Zhang K; Wang W; Fan M; Lin R Int J Surg; 2024 Apr; 110(4):2178-2186. PubMed ID: 38241384 [TBL] [Abstract][Full Text] [Related]
11. Lymph nodes ratio based nomogram predicts survival of resectable gastric cancer regardless of the number of examined lymph nodes. Chen S; Rao H; Liu J; Geng Q; Guo J; Kong P; Li S; Liu X; Sun X; Zhan Y; Xu D Oncotarget; 2017 Jul; 8(28):45585-45596. PubMed ID: 28489596 [TBL] [Abstract][Full Text] [Related]
12. Development and validation of a nomogram to predict the prognosis of patients with gastric cardia cancer. Shi X; Xu L; Ma B; Wang S Sci Rep; 2020 Aug; 10(1):14143. PubMed ID: 32839498 [TBL] [Abstract][Full Text] [Related]
13. Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer. Yang Y; Sun S; Wang Y; Xiong F; Xiao Y; Huang J Bosn J Basic Med Sci; 2021 Oct; 21(5):632-641. PubMed ID: 33577444 [TBL] [Abstract][Full Text] [Related]
14. Nomogram to predict overall survival of patients receiving radical gastrectomy and incomplete peri-operative adjuvant chemotherapy for stage II/III gastric cancer: a retrospective bi-center cohort study. Liu D; Quan H; Ma M; Zhou H; Yang X; Wu Z; Luo J; Xiao H; Xiao Y BMC Cancer; 2024 Mar; 24(1):344. PubMed ID: 38500085 [TBL] [Abstract][Full Text] [Related]
15. Nomograms for predicting survival in patients with metastatic gastric adenocarcinoma who undergo palliative gastrectomy. Ma T; Wu ZJ; Xu H; Wu CH; Xu J; Peng WR; Fan LL; Sun GP BMC Cancer; 2019 Aug; 19(1):852. PubMed ID: 31462229 [TBL] [Abstract][Full Text] [Related]
16. A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery. Mao Q; Xia W; Dong G; Chen S; Wang A; Jin G; Jiang F; Xu L J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1784-1792.e3. PubMed ID: 29554790 [TBL] [Abstract][Full Text] [Related]
17. Bladder cancer survival nomogram: Development and validation of a prediction tool, using the SEER and TCGA databases. Zhang Y; Hong YK; Zhuang DW; He XJ; Lin ME Medicine (Baltimore); 2019 Nov; 98(44):e17725. PubMed ID: 31689813 [TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma. Ge D; Luo Z; Mao R; Zhao H; Lv X; Zhao J; Zhou J; Huang Z; Zhang Y; Li Z; Bi X; Cai J Adv Ther; 2020 Jul; 37(7):3185-3205. PubMed ID: 32436026 [TBL] [Abstract][Full Text] [Related]
19. Nomogram for predicting the survival of gastric adenocarcinoma patients who receive surgery and chemotherapy. Wang CY; Yang J; Zi H; Zheng ZL; Li BH; Wang Y; Ge Z; Jian GX; Lyu J; Li XD; Ren XQ BMC Cancer; 2020 Jan; 20(1):10. PubMed ID: 31906882 [TBL] [Abstract][Full Text] [Related]
20. A SEER-based nomogram accurately predicts prognosis in Ewing's sarcoma. Zhan H; Mo F; Zhu M; Xu X; Zhang B; Liu H; Dai M Sci Rep; 2021 Nov; 11(1):22723. PubMed ID: 34811459 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]